Literature DB >> 2285739

Educational and psychosocial needs of patients with chronic disease. A survey of preferences of patients with rheumatoid arthritis.

L M Buckley, P Vacek, S M Cooper.   

Abstract

There is increasing interest in better defining and meeting the nonmedical needs of patients with chronic diseases, such as rheumatoid arthritis (RA). We surveyed patients with RA about the importance of eight psychosocial and eight educational issues, and asked patients from what source they preferred to get help with these issues and which sources they would not use. We also looked at individual variables, including sex, age, disease duration, and disease severity, to see if they affected patients' choices. The issues rated most important by patients included communicating with the doctor, understanding medication, dealing with pain, and the effects of arthritis on energy level, the future, and work. Most patients preferred to seek help from their physicians, although up to 75% were willing to attend groups, and 68% were willing to see individual counselors for some issues.

Entities:  

Mesh:

Year:  1990        PMID: 2285739

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  3 in total

1.  Preferences for arthritis interventions: identifying similarities and differences among African Americans and whites with osteoarthritis.

Authors:  Chivon A Mingo; Jessica M McIlvane; Malcolm Jefferson; Lloyd J Edwards; William E Haley
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

2.  Negative social perception of hypothetical workers with rheumatoid arthritis.

Authors:  Debra V McQuade
Journal:  J Behav Med       Date:  2002-06

3.  Rationale, design and conduct of a comprehensive evaluation of a primary care based intervention to improve the quality of life of osteoarthritis patients. The PraxArt-project: a cluster randomized controlled trial [ISRCTN87252339].

Authors:  Thomas Rosemann; Thorsten Körner; Michel Wensing; Jochen Gensichen; Christiane Muth; Stefanie Joos; Joachim Szecsenyi
Journal:  BMC Public Health       Date:  2005-07-19       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.